Royce Small-Cap Fund's Q1 2026 Performance Outshines Benchmark
Finance

Royce Small-Cap Fund's Q1 2026 Performance Outshines Benchmark

authorBy Morgan Housel
DateJul 06, 2026
Read time2 min
This report details the investment performance of the Royce Small-Cap Fund during the first quarter of 2026, highlighting its exceptional results compared to relevant market benchmarks and analyzing the contributing sector performances.

Royce Small-Cap Fund: Navigating Market Dynamics for Superior Returns

First Quarter 2026: A Period of Strong Growth for Small-Cap Investments

During the initial three months of 2026, the Royce Small-Cap Fund demonstrated remarkable performance, achieving a 3.90% increase. This impressive growth surpassed its primary benchmark, the Russell 2000 Index, which recorded a more modest gain of 0.89% over the same period, underscoring the Fund's effective investment strategies.

Sectoral Contributions to the Fund's Success

The stellar performance of the Fund was largely attributable to robust contributions from several key sectors. Information Technology, Industrials, and Materials emerged as the leading positive influencers, showcasing the strength and strategic positioning of the Fund's holdings within these areas. Conversely, the Health Care sector presented the most significant drag on performance, a notable shift considering its substantial positive impact in the preceding quarter (Q4 2025).

Market Overview: Small-Cap Indices Lead the Way

The closing quarter of 2025 proved to be dynamic for markets, with both the small-cap Russell 2000 and Russell Microcap Indexes registering positive returns. The micro-cap index, in particular, distinguished itself by leading all major domestic indexes, reinforcing the vibrant activity and potential within the smaller capitalization segment of the market.

More Articles
Finance
Marzetti: A Leader in Niche Food Markets with Strong Dividend Growth
Marzetti (MZTI) is a leading packaged food company specializing in frozen breads, dressings, dips, and sauces. The company boasts a 63-year streak of dividend growth and operates with no debt. Despite recent weak financial performance and economic sensitivities, the stock appears undervalued at approximately 17.1 times its fiscal year 2026 estimated earnings per share, significantly below its historical 5-year average. Its growth strategy relies on strategic acquisitions and brand licensing, exemplified by the recent purchase of Bachan's, enhancing its sauce portfolio. Marzetti's dividend is secure, offering a yield of around 3.45% with a manageable payout ratio and robust free cash flow.
By David RubensteinJul 06, 2026
Finance
Wipro: Buybacks and Sectoral Headwinds
Wipro Limited maintains a 'Hold' rating due to favorable buyback activity, despite persistent challenges in the business landscape. The company's recent $1.6 billion share repurchase, equivalent to 109.7% of its FY27 consensus earnings, highlights its attractive valuation and is expected to boost future earnings per share. However, disappointing results from industry peers, particularly Accenture, indicate ongoing difficulties with deal conversions and a challenging environment for the financial services sector, which could limit Wipro's short-term growth potential.
By Strive MasiyiwaJul 06, 2026
Finance
Mid-Cap Growth Portfolios Outperform in Q1 2026 Amid Market Declines
ClearBridge Mid Cap Growth Portfolios surpassed their benchmark, the Russell Midcap Growth Index, in Q1 2026. This success was attributed to a strategic cyclical positioning and robust performance across industrial and consumer staples sectors. Despite a broader market decline where mid-cap growth equities fell by 6.4%, these portfolios demonstrated resilience and effective management, particularly in capitalizing on improving end markets and AI infrastructure opportunities.
By Strive MasiyiwaJul 06, 2026
Finance
Universal Health Services: The Intricacies of Healthcare Stock Valuations
Universal Health Services' 'Hold' rating reflects a seemingly low valuation countered by significant financial hurdles. The company struggles with cash conversion due to high accounts receivable and faces margin pressure from policy changes impacting its high-margin Behavioral Health Services segment. This financial strain raises liquidity concerns, underscoring the complexity of assessing healthcare stocks beyond surface-level metrics.
By Suze OrmanJul 06, 2026
Finance
Cal-Maine Foods: A Commodity Stock with Cash Cow Attributes
Cal-Maine Foods is a leading player in its industry, characterized by strong competitive advantages, significant operational scale, a healthy financial position, and a consistent track record of shareholder returns. However, the company's earnings are inherently subject to cyclical fluctuations due to its commodity-driven business model. Despite this volatility, Cal-Maine's strategic acquisitions, low-cost operations, and improved product mix, particularly in specialty eggs, position it for long-term growth.
By Robert KiyosakiJul 06, 2026